1. Home
  2. APT vs MAIA Comparison

APT vs MAIA Comparison

Compare APT & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

HOLD

Current Price

$5.25

Market Cap

51.4M

Sector

N/A

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.95

Market Cap

49.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APT
MAIA
Founded
1983
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
49.3M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
APT
MAIA
Price
$5.25
$1.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.5K
1.3M
Earning Date
03-11-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$59,096,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.06
$0.87
52 Week High
$6.20
$3.19

Technical Indicators

Market Signals
Indicator
APT
MAIA
Relative Strength Index (RSI) 56.49 49.39
Support Level $4.96 $1.69
Resistance Level $5.64 $3.19
Average True Range (ATR) 0.27 0.27
MACD 0.02 -0.08
Stochastic Oscillator 40.58 17.00

Price Performance

Historical Comparison
APT
MAIA

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: